SE0203552D0 - Thrombin concentration - Google Patents

Thrombin concentration

Info

Publication number
SE0203552D0
SE0203552D0 SE0203552A SE0203552A SE0203552D0 SE 0203552 D0 SE0203552 D0 SE 0203552D0 SE 0203552 A SE0203552 A SE 0203552A SE 0203552 A SE0203552 A SE 0203552A SE 0203552 D0 SE0203552 D0 SE 0203552D0
Authority
SE
Sweden
Prior art keywords
thrombin solution
thrombin
solution
relates
initial
Prior art date
Application number
SE0203552A
Other languages
English (en)
Inventor
Stefan Winge
Peter Aizawa
Original Assignee
Biovitrum Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biovitrum Ab filed Critical Biovitrum Ab
Priority to SE0203552A priority Critical patent/SE0203552D0/sv
Publication of SE0203552D0 publication Critical patent/SE0203552D0/sv
Priority to PCT/SE2003/001548 priority patent/WO2004050700A1/en
Priority to AU2003267906A priority patent/AU2003267906A1/en

Links

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Surgery (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
SE0203552A 2002-12-02 2002-12-02 Thrombin concentration SE0203552D0 (sv)

Priority Applications (3)

Application Number Priority Date Filing Date Title
SE0203552A SE0203552D0 (sv) 2002-12-02 2002-12-02 Thrombin concentration
PCT/SE2003/001548 WO2004050700A1 (en) 2002-12-02 2003-10-06 Process for preparating concentrated thrombin solutions and use in fibrin glue
AU2003267906A AU2003267906A1 (en) 2002-12-02 2003-10-06 Process for preparating concentrated thrombin solutions and use in fibrin glue

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0203552A SE0203552D0 (sv) 2002-12-02 2002-12-02 Thrombin concentration

Publications (1)

Publication Number Publication Date
SE0203552D0 true SE0203552D0 (sv) 2002-12-02

Family

ID=20289727

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0203552A SE0203552D0 (sv) 2002-12-02 2002-12-02 Thrombin concentration

Country Status (3)

Country Link
AU (1) AU2003267906A1 (sv)
SE (1) SE0203552D0 (sv)
WO (1) WO2004050700A1 (sv)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE296109T1 (de) * 1996-03-20 2005-06-15 Baxter Ag Pharmazeutisches präparat zur behandlung von blutgerinnungsstörungen
DE10012732A1 (de) * 2000-03-18 2001-09-20 Aventis Behring Gmbh Thrombin-Zubereitungen und Verfahren zu ihrer Herstellung

Also Published As

Publication number Publication date
WO2004050700A1 (en) 2004-06-17
AU2003267906A1 (en) 2004-06-23

Similar Documents

Publication Publication Date Title
ATE476501T1 (de) Verfahren zur reinigung von factor vii
TW200505480A (en) High concentration antibody and protein formulations
EA200401525A1 (ru) Способы лечения гепатита (варианты )
PT813541E (pt) Processo de producao de uma proteina
EA200601555A1 (ru) Замещенные индазол-о-глюкозиды
DE60233955D1 (de) Spezifische bindungsmittel von human angiopoietin-2
NO20032674D0 (no) Isoindolin-1-on-glukokinase-aktivatorer
DE60133323D1 (de) Cardioprotektive Phosphonate
ATE425179T1 (de) Reinigung von glykopeptiden
DK1519944T3 (da) Fremgangsmåder til fremstilling af fibrinogen
WO2006114105A3 (en) Use of modified factor vii for treating bleeding
ATE432946T1 (de) Abtrennung von fibrinogen von plasmaproteasen
DE602007001467D1 (de) Therapeutische Zubereitung von hochreinem FVIIa und Verfahren zu dessen Gewinnung
ATE272436T1 (de) Mikrofiltration unter verwendung von aktivkohle
AU8184301A (en) Inhibitors for the blood-clotting factor xa
BR9915460A (pt) Método de tratamento de febre hemorrágica virótica
SE0203552D0 (sv) Thrombin concentration
ATE270327T1 (de) Verfahren zur präparation von humanem aktiviertem protein c
SE0203551D0 (sv) Prothrombin purification
GB0016362D0 (en) Tetraspanin modulation
MXPA05005915A (es) Soluciones de albumina humana terapeutica con baja actividad del activador de precalicreina (pka) y procedimiento de obtencion de las mismas.
DE60310240D1 (de) Entfernung von prionen-infektiosität
DK0846166T3 (da) Fremgangsmåde til thrombinfremstilling
WO2003073980A3 (en) Recombinant protein c variants
DK1275638T3 (da) Kombinationspræparat til behandling af immunologiske sygdomme